US Stock MarketDetailed Quotes

RNAZ Transcode Therapeutics

Watchlist

0.510
-0.027-4.94%

Trading Apr 16 13:31 ET

2.96MMarket Cap-4P/E (TTM)

Transcode Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

5.37%18.5M

-21.13%4.03M

23.30%5.3M

-7.08%4.34M

38.93%4.82M

198.89%17.55M

82.78%5.11M

84.63%4.3M

1,465.47%4.67M

672.14%3.47M

Selling and administrative expenses

-14.84%7.15M

-75.24%695.41K

3.95%1.98M

3.72%2.16M

44.73%2.31M

147.31%8.4M

65.15%2.81M

39.69%1.91M

1,351.75%2.09M

759.38%1.6M

-General and administrative expense

-14.84%7.15M

-75.24%695.41K

3.95%1.98M

3.72%2.16M

44.73%2.31M

147.31%8.4M

65.15%2.81M

39.69%1.91M

1,351.75%2.09M

759.38%1.6M

Research and development costs

19.85%12.26M

25.19%3.36M

9.81%3.34M

13.20%2.97M

37.72%2.59M

271.55%10.23M

109.00%2.69M

206.56%3.04M

1,137.31%2.62M

613.37%1.88M

Other operating expenses

14.57%-923.04K

92.90%-27.25K

95.81%-27.44K

-2,171.63%-788.94K

-1,036.04%-79.41K

-288.18%-1.08M

-102.47%-383.77K

-1,963.81%-654.95K

39.12%-34.73K

---6.99K

Operating profit

-5.37%-18.5M

21.13%-4.03M

-23.30%-5.3M

7.08%-4.34M

-38.93%-4.82M

-198.89%-17.55M

-82.78%-5.11M

-84.63%-4.3M

-1,465.47%-4.67M

-672.14%-3.47M

Net non-operating interest income expense

-337.23%-50.61K

-149.49%-55.76K

-98.54%131

-81.52%246

979.19%4.77K

87.74%-11.58K

-4,482.35%-22.35K

4,788.02%9K

103.17%1.33K

100.84%442

Non-operating interest income

-74.11%5.29K

-98.58%137

-98.54%131

-81.52%246

979.19%4.77K

2,973.80%20.41K

1,789.41%9.64K

6,283.69%9K

133,000.00%1.33K

3,583.33%442

Non-operating interest expense

74.76%55.9K

----

-66.36%31.99K

----

Other net income (expense)

Income before tax

-5.59%-18.55M

20.38%-4.09M

-23.55%-5.3M

7.06%-4.34M

-38.81%-4.82M

-156.67%-17.56M

-83.41%-5.13M

-84.13%-4.29M

-268.58%-4.67M

22.64%-3.47M

Income tax

Net income

-5.59%-18.55M

20.38%-4.09M

-23.55%-5.3M

7.06%-4.34M

-38.81%-4.82M

-156.67%-17.56M

-83.41%-5.13M

-84.13%-4.29M

-268.58%-4.67M

22.64%-3.47M

Net income continuous Operations

-5.59%-18.55M

20.38%-4.09M

-23.55%-5.3M

7.06%-4.34M

-38.81%-4.82M

-156.67%-17.56M

-83.41%-5.13M

-84.13%-4.29M

-268.58%-4.67M

22.64%-3.47M

Minority interest income

Net income attributable to the parent company

-5.59%-18.55M

20.38%-4.09M

-23.55%-5.3M

7.06%-4.34M

-38.81%-4.82M

-156.67%-17.56M

-83.41%-5.13M

-84.13%-4.29M

-268.58%-4.67M

22.64%-3.47M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-5.59%-18.55M

20.38%-4.09M

-23.55%-5.3M

7.06%-4.34M

-38.81%-4.82M

-156.67%-17.56M

-83.41%-5.13M

-84.13%-4.29M

-268.58%-4.67M

22.64%-3.47M

Basic earnings per share

-282.75%-4.14K

97.94%-6.5146

74.58%-67.2

54.31%-131.6

-22.22%-264

-67.10%-1.08K

-82.31%-316.39

-65.25%-264.4

-255.47%-288

28.02%-216

Diluted earnings per share

-282.75%-4.14K

97.94%-6.5146

74.58%-67.2

54.31%-131.6

-22.22%-264

-67.10%-1.08K

-82.31%-316.39

-65.25%-264.4

-255.47%-288

28.02%-216

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	5.37%18.5M	-21.13%4.03M	23.30%5.3M	-7.08%4.34M	38.93%4.82M	198.89%17.55M	82.78%5.11M	84.63%4.3M	1,465.47%4.67M	672.14%3.47M
Selling and administrative expenses	-14.84%7.15M	-75.24%695.41K	3.95%1.98M	3.72%2.16M	44.73%2.31M	147.31%8.4M	65.15%2.81M	39.69%1.91M	1,351.75%2.09M	759.38%1.6M
-General and administrative expense	-14.84%7.15M	-75.24%695.41K	3.95%1.98M	3.72%2.16M	44.73%2.31M	147.31%8.4M	65.15%2.81M	39.69%1.91M	1,351.75%2.09M	759.38%1.6M
Research and development costs	19.85%12.26M	25.19%3.36M	9.81%3.34M	13.20%2.97M	37.72%2.59M	271.55%10.23M	109.00%2.69M	206.56%3.04M	1,137.31%2.62M	613.37%1.88M
Other operating expenses	14.57%-923.04K	92.90%-27.25K	95.81%-27.44K	-2,171.63%-788.94K	-1,036.04%-79.41K	-288.18%-1.08M	-102.47%-383.77K	-1,963.81%-654.95K	39.12%-34.73K	---6.99K
Operating profit	-5.37%-18.5M	21.13%-4.03M	-23.30%-5.3M	7.08%-4.34M	-38.93%-4.82M	-198.89%-17.55M	-82.78%-5.11M	-84.63%-4.3M	-1,465.47%-4.67M	-672.14%-3.47M
Net non-operating interest income expense	-337.23%-50.61K	-149.49%-55.76K	-98.54%131	-81.52%246	979.19%4.77K	87.74%-11.58K	-4,482.35%-22.35K	4,788.02%9K	103.17%1.33K	100.84%442
Non-operating interest income	-74.11%5.29K	-98.58%137	-98.54%131	-81.52%246	979.19%4.77K	2,973.80%20.41K	1,789.41%9.64K	6,283.69%9K	133,000.00%1.33K	3,583.33%442
Non-operating interest expense	74.76%55.9K	----	----	----	----	-66.36%31.99K	----	----	----	----
Other net income (expense)
Income before tax	-5.59%-18.55M	20.38%-4.09M	-23.55%-5.3M	7.06%-4.34M	-38.81%-4.82M	-156.67%-17.56M	-83.41%-5.13M	-84.13%-4.29M	-268.58%-4.67M	22.64%-3.47M
Income tax
Net income	-5.59%-18.55M	20.38%-4.09M	-23.55%-5.3M	7.06%-4.34M	-38.81%-4.82M	-156.67%-17.56M	-83.41%-5.13M	-84.13%-4.29M	-268.58%-4.67M	22.64%-3.47M
Net income continuous Operations	-5.59%-18.55M	20.38%-4.09M	-23.55%-5.3M	7.06%-4.34M	-38.81%-4.82M	-156.67%-17.56M	-83.41%-5.13M	-84.13%-4.29M	-268.58%-4.67M	22.64%-3.47M
Minority interest income
Net income attributable to the parent company	-5.59%-18.55M	20.38%-4.09M	-23.55%-5.3M	7.06%-4.34M	-38.81%-4.82M	-156.67%-17.56M	-83.41%-5.13M	-84.13%-4.29M	-268.58%-4.67M	22.64%-3.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-5.59%-18.55M	20.38%-4.09M	-23.55%-5.3M	7.06%-4.34M	-38.81%-4.82M	-156.67%-17.56M	-83.41%-5.13M	-84.13%-4.29M	-268.58%-4.67M	22.64%-3.47M
Basic earnings per share	-282.75%-4.14K	97.94%-6.5146	74.58%-67.2	54.31%-131.6	-22.22%-264	-67.10%-1.08K	-82.31%-316.39	-65.25%-264.4	-255.47%-288	28.02%-216
Diluted earnings per share	-282.75%-4.14K	97.94%-6.5146	74.58%-67.2	54.31%-131.6	-22.22%-264	-67.10%-1.08K	-82.31%-316.39	-65.25%-264.4	-255.47%-288	28.02%-216
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall